Hanover Portfolio Acquisitions, Inc. announced that under the terms of the acquisition, Dr. Donnie Rudd, PhD, President of WeHealAnimals and a NASA recognized inventor for his work in stem cell research, has joined Hanover as its Chief Scientist and Director of Intellectual Property.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0013 USD | -7.14% | +18.18% | -85.06% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
1st Jan change | Capi. | |
---|---|---|
-85.06% | 454K | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ENDV Stock
- News Endonovo Therapeutics, Inc.
- Hanover Portfolio Acquisitions, Inc. Appoints Donnie Rudd as Director of Intellectual Property